These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1414 related items for PubMed ID: 17980364

  • 21. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T, Samara M, Constantinidis T, Tziomalos K, Krassas G.
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [Abstract] [Full Text] [Related]

  • 22. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
    Moran C, Renteria JL, Moran S, Herrera J, Gonzalez S, Bermudez JA.
    Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.
    Tolino A, Gambardella V, Caccavale C, D'Ettore A, Giannotti F, D'Antò V, De Falco CL.
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar 01; 119(1):87-93. PubMed ID: 15734091
    [Abstract] [Full Text] [Related]

  • 24. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.
    Clin Endocrinol (Oxf); 2004 Dec 01; 61(6):738-46. PubMed ID: 15579189
    [Abstract] [Full Text] [Related]

  • 25. Serum resistin levels in women with polycystic ovary syndrome.
    Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D.
    Fertil Steril; 2004 Feb 01; 81(2):361-6. PubMed ID: 14967374
    [Abstract] [Full Text] [Related]

  • 26. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B, Radzikowska M, Wasilewska-Dziubińska E, Kapliński A, Roguski K, Płonowski A.
    Gynecol Endocrinol; 1999 Oct 01; 13(5):344-51. PubMed ID: 10599552
    [Abstract] [Full Text] [Related]

  • 27. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW, Kilpatrick ES, Keevil BG, Coady AM, Atkin SL.
    Clin Endocrinol (Oxf); 2009 Feb 01; 70(2):233-7. PubMed ID: 18547343
    [Abstract] [Full Text] [Related]

  • 28. ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance.
    Uncu G, Ozyurek SE, Uncu Y.
    Fertil Steril; 2007 Sep 01; 88(3):670-4. PubMed ID: 17451692
    [Abstract] [Full Text] [Related]

  • 29. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
    Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Katsikis I.
    Clin Endocrinol (Oxf); 2014 Mar 01; 80(3):432-8. PubMed ID: 23909452
    [Abstract] [Full Text] [Related]

  • 30. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V, Nagamani M.
    J Soc Gynecol Investig; 2005 Feb 01; 12(2):129-34. PubMed ID: 15695109
    [Abstract] [Full Text] [Related]

  • 31. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V, Barash A, Shoham Z, Koistinen R, Seppala M, Hen M, Lunenfeld B, Zadik Z.
    Isr J Med Sci; 1994 Jan 01; 30(1):42-7. PubMed ID: 7511134
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH, von Eye Corleta H, Capp E, Spritzer PM.
    Horm Metab Res; 2003 Feb 01; 35(2):86-91. PubMed ID: 12734787
    [Abstract] [Full Text] [Related]

  • 34. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM.
    Nutr Res; 2011 Feb 01; 31(2):97-103. PubMed ID: 21419313
    [Abstract] [Full Text] [Related]

  • 35. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I.
    Hum Reprod; 2009 Nov 01; 24(11):2917-23. PubMed ID: 19617605
    [Abstract] [Full Text] [Related]

  • 36. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
    Maciel GA, Soares Júnior JM, Alves da Motta EL, Abi Haidar M, de Lima GR, Baracat EC.
    Fertil Steril; 2004 Feb 01; 81(2):355-60. PubMed ID: 14967373
    [Abstract] [Full Text] [Related]

  • 37. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
    Belli SH, Graffigna MN, Oneto A, Otero P, Schurman L, Levalle OA.
    Fertil Steril; 2004 Mar 01; 81(3):624-9. PubMed ID: 15037412
    [Abstract] [Full Text] [Related]

  • 38. The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.
    Nafiye Y, Sevtap K, Muammer D, Emre O, Senol K, Leyla M.
    Fertil Steril; 2010 Apr 01; 93(6):1864-9. PubMed ID: 19171332
    [Abstract] [Full Text] [Related]

  • 39. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H, Takahashi K, Miyazaki K.
    Arch Gynecol Obstet; 2007 Mar 01; 275(3):169-73. PubMed ID: 16972071
    [Abstract] [Full Text] [Related]

  • 40. Retention of estradiol negative feedback relationship to LH predicts ovulation in response to caloric restriction and weight loss in obese patients with polycystic ovary syndrome.
    van Dam EW, Roelfsema F, Veldhuis JD, Hogendoorn S, Westenberg J, Helmerhorst FM, Frölich M, Krans HM, Meinders AE, Pijl H.
    Am J Physiol Endocrinol Metab; 2004 Apr 01; 286(4):E615-20. PubMed ID: 14678951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 71.